Titan Peptide Lab scores Moderate Transparency with notably strong batch traceability - lot codes appear on the bottle, the release sheet, and the order confirmation, creating a consistent chain a buyer can follow. The 6-parameter COA is more complete than most in this range. What holds the score at Moderate rather than High is straightforward: Titan explicitly states it does not issue third-party per-lot purity certificates, which caps the Third-Party Testing dimension. The operation launched in 2026, so operational track record is minimal by definition.
| Dimension | Max | Notes | Score |
|---|---|---|---|
| Third-Party Testing Practice | 30 | Per-batch testing across all 11 SKUs confirmed. Six parameters tested: identity (ESI-MS), purity (HPLC-UV), sterility (USP <71>), endotoxin (LAL), heavy metals (ICP-MS via ISO 17025 partner), residual solvents (GC-FID). The ISO 17025 partner handles heavy metals only - an independent, accredited third party. Purity and identity, the signals buyers most need verified, are conducted entirely in-house. Titan explicitly states no third-party per-lot purity certificate is issued. In-house testing with one external parameter rather than fully independent purity verification. | 18/30 |
| Batch Traceability & Verification | 20 | Lot code format TPL-YYMM-[A-Z] appears on the bottle, the in-house release sheet, and the order record. The lot-matched release sheet ships in the box. Lost copies can be reissued via email with a lot number. Product pages display current lot codes (Lot 04-A through 04-K) confirming per-batch documentation rather than rotating a single certificate across SKUs. No QR code resolving directly to a third-party lab database, which would be the gold standard, but lot-matched documentation verified against the bottle code is strong. | 17/20 |
| COA Accessibility | 15 | A specimen COA is publicly downloadable on the lab testing page, labeled clearly as "for reference only." The actual per-lot release sheets are not in a public searchable database - they ship in the box with orders and can be requested via email with a lot number. Access tier: email-on-request. Better than login-gated or image-only; below open public database. | 10/15 |
| COA Completeness | 15 | The specimen COA shows: identity (ESI-MS, exact m/z value with pass/fail against theoretical), purity (HPLC-UV, exact area percentage), sterility (USP <71>, result), endotoxin (LAL, EU/mg value), heavy metals (ICH Q3D compliance), residual solvents (GC-FID, threshold result). Six parameters documented with methods and specs stated. Minor deduction: underlying chromatogram not shown on the specimen COA, only the purity percentage result. Among the more complete COA formats observed in this market. | 14/15 |
| Testing Recency | 10 | Specimen COA on the lab testing page carries synthesis date 2026-04-02 and testing dates 2026-04-06 and 2026-04-08 - recently produced and recently tested. Product pages display active current lot codes. Documentation is dated and demonstrably current relative to product on sale. Minor deduction for not displaying a "last reviewed" timestamp on the lab testing page itself. | 9/10 |
| Policy Transparency | 5 | Refund policy is published at a dedicated URL. Covers: 14-day unopened returns, quality guarantee for lot-mismatch and documented quality issues, 48-hour window for damage claims, RMA process described, crypto-refund mechanism explained. Specific and complete. No vague "contact us" placeholder - actual terms and timelines stated. | 5/5 |
| Operational Track Record | 5 | Copyright reads 2026. Lot codes are in TPL-26xx format indicating 2026 production. The operation appears less than one year old based on public evidence. Listed on PeptideSuppliers.org and reviewed by Peptide-News.com, suggesting some third-party acknowledgment, but multi-year verifiable track record is absent. New does not mean unreliable, but the dimension exists to distinguish established from unproven operations. | 2/5 |
| Total | 75/100 |